drugset / Trial / NCT01017042
Pharmacokinetic Study of an Acute Gout Regimen
Non-randomizedSingle-groupOpen-labelBasic science
Summary
This study aims to characterize the pharmacokinetic profile of colchicine after a regimen of 1.8 mg over two hours. A secondary goal is to evaluate the safety and tolerability of this regimen in healthy volunteers. To this end, all study subjects will be monitored for adverse effects throughout the entire study period.
Timeline
- Start
- 2007-09
- Primary completion
- 2007-09
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colchicine | Small molecule | 1.8 mg | Oral |
Indications
No indication recorded.